Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harms

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Human Immunology|September 1, 1995
CD8+ lymphocytes that kill allogeneic and xenogeneic major histocompatibility complex class I targetsJ S Harms, G A Splitter
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2013
Isolation of murine postnatal brain microglia for phenotypic characterization using magnetic cell separation technologyAshley S Harms, Malú G Tansey
Immunogenetics|January 1, 1994
The enhancer A/IRS region of a cattle MHC class I promoterJ S Harms, G A Splitter
Frontiers in Aging Neuroscience|March 23, 2026
Interconnected roles of astrocytes and the blood-brain barrier in Parkinson's disease: pathological evidence, mechanistic insights, and knowledge gapsAnna C Stoll, Ashley S Harms
Frontiers in Cellular Neuroscience|July 19, 2023
Editorial: Glial-targeted therapeutics for CNS disease: getting there from hereMalú Gámez Tansey, Ashley S Harms
Immunogenetics|January 1, 1992
Impairment of MHC class I transcription in a mutant bovine B cell lineJ S Harms, G A Splitter
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2014
Monocytes and Parkinson's disease: invaders from outside?A S Harms, D G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2018
Glial GLP1R: A novel neuroprotector?Aubrey M Schonhoff, Ashley S Harms
Human Gene Therapy|October 1, 1995
Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoterJ S Harms, G A Splitter
AJR. American Journal of Roentgenology|August 1, 1996
Mucinous carcinoma of the breast: potential false-negative MR imaging interpretationR W Miller, S Harms, A Alvarez
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Human Immunology|September 1, 1995
CD8+ lymphocytes that kill allogeneic and xenogeneic major histocompatibility complex class I targetsJ S Harms, G A Splitter
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2013
Isolation of murine postnatal brain microglia for phenotypic characterization using magnetic cell separation technologyAshley S Harms, Malú G Tansey
Immunogenetics|January 1, 1994
The enhancer A/IRS region of a cattle MHC class I promoterJ S Harms, G A Splitter
Frontiers in Aging Neuroscience|March 23, 2026
Interconnected roles of astrocytes and the blood-brain barrier in Parkinson's disease: pathological evidence, mechanistic insights, and knowledge gapsAnna C Stoll, Ashley S Harms
Frontiers in Cellular Neuroscience|July 19, 2023
Editorial: Glial-targeted therapeutics for CNS disease: getting there from hereMalú Gámez Tansey, Ashley S Harms
Immunogenetics|January 1, 1992
Impairment of MHC class I transcription in a mutant bovine B cell lineJ S Harms, G A Splitter
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2014
Monocytes and Parkinson's disease: invaders from outside?A S Harms, D G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2018
Glial GLP1R: A novel neuroprotector?Aubrey M Schonhoff, Ashley S Harms
Human Gene Therapy|October 1, 1995
Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoterJ S Harms, G A Splitter
AJR. American Journal of Roentgenology|August 1, 1996
Mucinous carcinoma of the breast: potential false-negative MR imaging interpretationR W Miller, S Harms, A Alvarez
Pageof 17